Trial Profile
Evaluation of Adherence and Persistence to Tocilizumab in Combination With Methotrexate or Tocilizumab Monotherapy in Patients With Moderate to Severe Active Rheumatoid Arthritis in Local Environment
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 08 Nov 2021
Price :
$35
*
At a glance
- Drugs Tocilizumab (Primary) ; Methotrexate
- Indications Rheumatoid arthritis
- Focus Therapeutic Use
- Sponsors Roche
- 15 Feb 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 25 Mar 2010 Planned number of patients changed from 32 to 35 as reported by Roche record.
- 18 Feb 2010 Planned number of patients changed from 35 to 32 as reported by ClinicalTrials.gov.